Any forward-looking statement made in this Form 10-Q is based only on information currently available to us and speaks only as of the date on which it is made.Of the $49.2 million expense recorded, $47.2 million and $2.0 million was recorded within our Dental and Animal Health segments, respectively.Dental segment operating income was $61.0 million and $55.6 million for the three months ended October 29, 2022 and October 30, 2021, respectively.Animal Health segment operating income was $28.3 million and $26.1 million for the three months ended October 29, 2022, and October 30, 2021, respectively.Corporate segment operating loss was $29.2 million and $18.8 million for the three months ended October 29, 2022 and October 30, 2021, respectively.Net other income was $10.7 million and $1.3 million for the three months ended October 29, 2022 and October 30, 2021, respectively.Corporate segment operating loss was $53.1 million and $81.1 million for the six months ended October 29, 2022 and October 30, 2021, respectively.Net other income was $6.9 million and $85.3 million for the six months ended October 29, 2022 and October 30, 2021, respectively.LIQUIDITY AND CAPITAL RESOURCESNet cash used in operating activities was $520.2 million and $539.0 million for the six months ended October 29, 2022 and October 30, 2021, respectively.Net cash provided by investing activities was $447.9 million and $607.6 million for the six months ended October 29, 2022 and October 30, 2021, respectively.Collections of DPP receivables were $489.6 million and $585.6 million for the six months ended October 29, 2022 and October 30, 2021, respectively.Capital expenditures were $26.8 million and $15.5 million during the six months ended October 29, 2022 and October 30, 2021, respectively.